1. A Novel Three-Gene Model Predicts Prognosis and Therapeutic Sensitivity in Esophageal Squamous Cell Carcinoma
   Fa-Min Zeng et al, 2019, BioMed Research International CrossRef
2. Cancer Biology of the Endoplasmic Reticulum Lectin Chaperones Calreticulin, Calnexin and PDIA3/ERp57
   Shing Tat Theodore Lam et al, 2021, Cellular Biology of the Endoplasmic Reticulum CrossRef
3. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy
   Jing Zhang et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
4. Clinical Significance of Serum Haptoglobin and Protein Disulfide-Isomerase A3 in the Screening, Diagnosis, and Staging of Colorectal Cancer
   Yajin Niu et al, 2022, Frontiers in Pharmacology CrossRef
5. Protein disulfide isomerase A3 as novel biomarker for endometrial cancer
   Fanrong Yu et al, 2023, Frontiers in Oncology CrossRef
6. Glioblastoma: Current Status, Emerging Targets, and Recent Advances
   Amandeep Thakur et al, 2022, Journal of Medicinal Chemistry CrossRef
7. Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients
   Zhigang Peng et al, 2020, Aging CrossRef
8. Correlation between low expression of protein disulfide isomerase A3 and lymph node metastasis in papillary thyroid carcinoma and poor prognosis: a clinicopathological study of 1,139 cases with long-term follow-up
   Shoko Kure et al, 2022, Endocrine Journal CrossRef
9. Expression and Prognostic Significance of PDIA3 in Cervical Cancer
   Jing Zhang et al, 2022, International Journal of Genomics CrossRef
10. PDIA3 driven STAT3/PD-1 signaling promotes M2 TAM polarization and aggravates colorectal cancer progression
    Jianchun Fan et al, 2024, Aging CrossRef